查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2133528

2026年體外診斷（IVD）人工智慧（AI）全球市場報告

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外診斷（IVD）領域的人工智慧（AI）市場發展迅速。預計該市場規模將從2025年的5.3億美元成長到2026年的6.4億美元，複合年成長率（CAGR）為20.2%。這一成長主要歸功於對精準診斷需求的不斷成長、實驗室基礎設施的不斷改進、慢性病患病率的上升、數位化診斷工具的廣泛應用以及生物標記研究的進步。

未來幾年，體外診斷（IVD）領域的人工智慧（AI）市場預計將快速成長。預計到2030年，該市場將以19.8%的複合年成長率成長，達到13.3億美元。預測期內的成長要素包括：雲端診斷平台的擴展、人工智慧與基因組學融合的進步、人工智慧驅動的即時診斷技術的開發、個人化醫療投資的增加以及對快速且經濟高效的檢測日益成長的需求。預測期內的關鍵趨勢包括：人工智慧驅動的檢查室自動化、疾病預測性診斷、數據驅動的檢測結果解讀、雲端診斷平台的擴展以及個人化患者畫像。

日益成長的個人化醫療需求預計將推動體外診斷（IVD）領域人工智慧（AI）市場的發展。個人化醫療是指根據個人的基因譜、生活方式和環境因素，最佳化預防、診斷和治療的醫療方法。隨著基因組數據和定序技術的進步，能夠為個別患者量身定做更精準、更有針對性、更有效的治療方案，個人化醫療正在不斷發展。人工智慧（AI）在體外診斷（IVD）領域的應用，透過分析複雜的診斷資訊來識別患者特有的疾病模式，從而支持個人化醫療，並實現精準、及時且以患者為中心的治療決策。例如，根據美國非營利組織個人化醫療聯盟（Personalized Medicine Coalition）2024年2月發布的數據顯示，美國食品藥物管理局（FDA）在2023年批准了16種針對罕見疾病患者的新型個人化療法，而2022年僅批准了6種。 2023年新獲準的個人化療法包括7種抗癌藥物和3種其他疾病的治療藥物。因此，對個人化醫療日益成長的需求正在推動體外診斷（IVD）領域人工智慧（AI）市場的成長。

在體外診斷 (IVD) 人工智慧 (AI) 市場領先的公司正致力於開發先進的解決方案，例如獲得 CE-IVDR 認證的高透明度 AI 平台，旨在提高診斷準確性、簡化工作流程並支援為每位患者提供個人化醫療服務。獲得 CE-IVDR 認證的高透明度 AI 平台是用於體外診斷的 AI 系統，符合歐盟監管標準，並提供清晰、可審計且易於理解的決策流程。例如，總部位於英國的診斷檢測公司 Diagnostics.ai 於 2025 年 5 月推出了 PCR.AI，這是一款旨在加速和提高 PCR 診斷準確性的智慧解決方案。此解決方案能夠自動且快速解讀即時PCR檢查室效率，最大限度地減少了錯誤，並實現了分子診斷的無縫監管合規性。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球體外診斷（IVD）人工智慧（AI）市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 人工智慧和自主智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 生物技術、基因組學和精準醫療
    • 物聯網、智慧基礎設施、互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 人工智慧驅動的實驗室自動化
    • 預測性疾病診斷
    • 基於數據的測試結果解讀
    • 基於雲端的診斷平台
    • 為每位患者建立個人化檔案

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 研究機構
  • 製藥公司
  • 醫療設備製造商

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球體外診斷（IVD）人工智慧（AI）市場：PESTEL分析
  • 全球體外診斷（IVD）人工智慧（AI）市場：規模、對比及成長率分析
  • 全球人工智慧（AI）在體外診斷（IVD）領域的市場表現：規模與成長，2020-2025年
  • 全球體外診斷（IVD）人工智慧（AI）市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按組件
  • 軟體、硬體和服務
  • 透過技術
  • 機器學習、自然語言處理、電腦視覺、機器人技術、流程自動化、深度學習
  • 按部署模式
  • 雲端部署、本地部署、混合部署
  • 透過使用
  • 診斷影像、臨床實驗室檢測、病理學、基因組學、個人化醫療
  • 最終用戶
  • 醫院和診所、檢測實驗室、研究機構、製藥公司、醫療設備製造商
  • 按類型細分：軟體
  • 診斷演算法、數據分析平台、決策支援系統
  • 按類型細分：硬體
  • 實驗室設備、醫學影像設備、即時診斷設備
  • 按類型細分：服務
  • 諮詢與實施、維護與支援、訓練與教育

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 體外診斷（IVD）人工智慧（AI）市場：競爭格局和市場佔有率，2024年
  • 體外診斷（IVD）領域人工智慧（AI）市場：公司估值矩陣
  • 體外診斷（IVD）領域的人工智慧（AI）市場：公司概況
    • Roche Diagnostics GmbH
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章 其他大型企業和創新企業

  • Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN NV, Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

  • 2030年體外診斷（IVD）人工智慧（AI）市場：提供新機會的國家
  • 2030年體外診斷（IVD）人工智慧（AI）市場：充滿新機會的細分市場
  • 2030年體外診斷（IVD）人工智慧（AI）市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: ME4MAIAI10_G26Q1

Artificial intelligence (AI) in in vitro diagnostics (IVD) refers to the application of advanced algorithms to analyze medical data generated from laboratory tests conducted on samples such as blood, tissue, or urine. It enables faster, more accurate, and data-driven interpretation of test results, supporting early disease detection, personalized treatment decisions, and enhanced diagnostic efficiency.

The main components of artificial intelligence (AI) in in vitro diagnostics (IVD) include software, hardware, and services. Software is a set of programs and data that enables a computer to perform specific tasks. It utilizes technologies such as machine learning, natural language processing, computer vision, robotic process automation, and deep learning, and is deployed through cloud-based, on-premise, and hybrid methods. These technologies are applied in areas including diagnostic imaging, laboratory testing, pathology, genomics, and personalized medicine, and cater to end users such as hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical companies, and medical device manufacturers.

Tariffs are affecting the AI in vitro diagnostics market by increasing the costs of importing laboratory instruments, diagnostic software, and biomarker testing kits, particularly across the Asia-Pacific and European regions. Hardware-intensive segments such as laboratory instruments and imaging devices are most affected, resulting in delays and higher operational costs for diagnostic laboratories. On the positive side, tariffs are encouraging local production and innovation, leading to more cost-efficient AI-based diagnostic solutions and strengthening regional manufacturing capabilities.

The artificial intelligence (AI) in in vitro diagnostics (ivd) market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in in vitro diagnostics (ivd) market statistics, including artificial intelligence (AI) in in vitro diagnostics (ivd) industry global market size, regional shares, competitors with a artificial intelligence (AI) in in vitro diagnostics (ivd) market share, detailed artificial intelligence (AI) in in vitro diagnostics (ivd) market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in in vitro diagnostics (ivd) industry. This artificial intelligence (AI) in in vitro diagnostics (ivd) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) in in vitro diagnostics (ivd) market size has grown exponentially in recent years. It will grow from $0.53 billion in 2025 to $0.64 billion in 2026 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to increasing demand for accurate diagnostics, expansion of laboratory infrastructure, rising prevalence of chronic diseases, growing adoption of digital diagnostic tools, and advancements in biomarker research.

The artificial intelligence (AI) in in vitro diagnostics (ivd) market size is expected to see rapid growth in the next few years. It will grow to $1.33 billion in 2030 at a compound annual growth rate (CAGR) of 19.8%. The growth during the forecast period can be attributed to the expansion of cloud-based diagnostic platforms, increasing integration of AI with genomics, development of AI-enabled point-of-care diagnostics, growing investments in personalized medicine, and rising demand for rapid and cost-effective testing. Major trends during the forecast period include AI-enabled laboratory automation, predictive disease diagnostics, data-driven test interpretation, expansion of cloud-based diagnostic platforms, and personalized patient profiling.

The increasing demand for personalized medicine is anticipated to support the growth of artificial intelligence (AI) in the in vitro diagnostics (IVD) market going forward. Personalized medicine refers to a healthcare approach that tailors prevention, diagnosis, and treatment according to an individual's genetic profile, lifestyle, and environmental factors. Personalized medicine is expanding as advancements in genomic data and sequencing technologies enable more accurate, targeted, and effective treatments that are customized to individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) supports personalized medicine by analyzing complex diagnostic information to identify patient-specific disease patterns, enabling accurate, timely, and customized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, compared with six in 2022. The newly approved personalized treatments in 2023 also included seven cancer drugs and three treatments for other diseases and conditions. Therefore, the increasing demand for personalized medicine is driving the growth of artificial intelligence (AI) in the in vitro diagnostics (IVD) market.

Key companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are focusing on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is an AI system used for in vitro diagnostics that complies with EU regulatory standards and provides clear, auditable, and understandable decision-making processes. For example, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, a smart solution designed to accelerate and improve PCR diagnostics. The solution automates and accelerates the interpretation of real-time PCR diagnostics with more than 99.9% accuracy. It provides transparency by clearly demonstrating how each result is generated, supporting regulatory compliance and increasing clinical trust. This substantially improves laboratory efficiency, minimizes errors, and enables seamless regulatory adherence for molecular diagnostics.

In April 2025, bioMerieux SA, a France-based technology company specializing in artificial intelligence (AI) for in vitro diagnostics (IVD), entered into a partnership with Mila to advance AI-driven diagnostic research and innovation. This partnership aims to develop advanced AI solutions that improve the accuracy and efficiency of in vitro diagnostic tools and enhance the detection of antibiotic resistance. Mila is a Canada-based artificial intelligence research institute recognized for its cutting-edge research in machine learning.

Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market includes revenues earned by entities by providing services such as predictive analytics services, remote diagnostic and telepathology services, workflow automation, optimization services, data annotation, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in in vitro diagnostics (IVD) market also includes sales of automated laboratory instruments, artificial intelligence-enabled digital pathology scanners, and liquid biopsy diagnostic kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) in in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Technology: Machine Learning; Natural Language Processing; Computer Vision; Robotics Process Automation; Deep Learning
  • 3) By Deployment Model: Cloud-Based; On-Premise; Hybrid
  • 4) By Application: Diagnostic Imaging; Laboratory Testing; Pathology; Genomics; Personalized Medicine
  • 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Medical Device Manufacturers
  • Subsegments:
  • 1) By Software: Diagnostic Algorithms; Data Analytics Platforms; Decision Support Systems
  • 2) By Hardware: Laboratory Instruments; Imaging Devices; Point-Of-Care Devices
  • 3) By Services: Consulting And Implementation; Maintenance And Support; Training And Education
  • Companies Mentioned: Roche Diagnostics GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Illumina Inc.; Hologic Inc.; Sysmex Corporation; QIAGEN N.V.; Tempus Labs Inc.; BillionToOne Inc.; PathAI Inc.; Proscia Inc.; Indica Labs Inc.; Visiopharm A/S; aetherAI Co. Ltd.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; OncoHost Ltd.; Qritive; Aiforia Technologies Oyj
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Ai-Enabled Laboratory Automation
    • 4.2.2 Predictive Disease Diagnostics
    • 4.2.3 Data-Driven Test Interpretation
    • 4.2.4 Cloud-Based Diagnostic Platforms
    • 4.2.5 Personalized Patient Profiling

5. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Pharmaceutical Companies
  • 5.5 Medical Device Manufacturers

6. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segmentation

  • 9.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Hardware, Services
  • 9.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning
  • 9.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cloud-Based, On-Premise, Hybrid
  • 9.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine
  • 9.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers
  • 9.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems
  • 9.7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Instruments, Imaging Devices, Point-Of-Care Devices
  • 9.8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting And Implementation, Maintenance And Support, Training And Education

10. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regional And Country Analysis

  • 10.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 11.1. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 12.1. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 13.1. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 14.1. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 15.1. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 16.1. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 17.1. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 18.1. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 19.1. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 20.1. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 21.1. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 22.1. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 23.1. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 24.1. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 25.1. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 26.1. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 27.1. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 28.1. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 29.1. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 30.1. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 31.1. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 32.1. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 33.1. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 34.1. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

  • 36.1. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Company Profiles
    • 36.3.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

  • Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive

38. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

40. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

  • 40.1 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer